ALT

Altimmune Stock Analysis

AI Rating

Low
  • Quality2/10
  • Growth↑ 5/10
  • Value↓ 0/10
Altimmune sales and earnings growth
ALT Growth
Neutral
  • Revenue Y/Y↑ 105.00%
  • EPS Y/Y↑ 25.37%
  • FCF Y/Y↑ 15.41%
Altimmune gross and profit margin trends
ALT Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -214861.00%
  • ROIC 5Y↓ -116.44%
Altimmune net debt vs free cash flow
ALT Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -53.3

Altimmune stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗